Chao Kan

Title: Chao Kan: Innovator in Pharmaceutical Chemistry

Introduction

Chao Kan is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on chemical compounds with therapeutic applications. His research has led to advancements that hold promise for medical treatments.

Latest Patents

Chao Kan holds a patent for a compound titled "Triazinylmethylcycloalkylcarboxylic acid derivative, and pharmaceutical composition and use thereof." This substituted triazinylmethylcycloalkylcarboxylic acid derivative exhibits a structure as shown in formula (I). The patent further discloses a pharmaceutically acceptable salt, a stereoisomer, a pharmaceutical composition, and the use of the derivative. The compound demonstrates significant P2X3 inhibitory activity and selectivity, indicating its high application value in therapeutic contexts.

Career Highlights

Throughout his career, Chao Kan has worked with prominent companies in the pharmaceutical industry. He has been associated with Shanghai Haiyan Pharmaceutical Technology Co., Ltd. and Yangtze River Pharmaceutical Group Co., Ltd. His work in these organizations has contributed to the development of innovative pharmaceutical solutions.

Collaborations

Chao Kan has collaborated with esteemed colleagues, including Bin Hu and Jingfeng Zhu. These partnerships have fostered a collaborative environment that enhances research and development efforts in the pharmaceutical sector.

Conclusion

Chao Kan's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a key inventor in the field. His work continues to influence the development of valuable therapeutic compounds.